Topic summary
Avitriptan
Avitriptan (INN; development code BMS-180048) is an antimigraine drug of the triptan family which was never marketed. It acts as a serotonin5-HT1B and 5-HT1D receptoragonist. The drug reached phase 3clinical trials prior to the discontinuation of its development.